Fiona Okoroti
Gerontology · Rockford, ILNPI 1700338720
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,804, more than ten times the $120 reported in 2022. Among gerontology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $26.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$637
- AbbVie$606
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$564
- Neurocrine Biosciences, Inc.$492
- Alkermes, Inc.$283
- Otsuka America Pharmaceutical, Inc.$271
- plus $1K from 12 others
What the payments were for
- Food & beverage$4,20097%
- Education$1113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $637 |
| AbbVie | 28 | $606 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $564 |
| Neurocrine Biosciences, Inc. | 16 | $492 |
| Alkermes, Inc. | 9 | $283 |
| Otsuka America Pharmaceutical, Inc. | 9 | $271 |
| E.r. Squibb & Sons, L.L.C. | 21 | $245 |
| Supernus Pharmaceuticals, Inc. | 7 | $206 |
| Johnson & Johnson | 4 | $193 |
| Harmony Biosciences LLC | 6 | $137 |
| Vanda Pharmaceuticals Inc. | 4 | $127 |
| Novo Nordisk | 1 | $125 |
| Lundbeck LLC | 5 | $119 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Smith+Nephew | 1 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Sanofi-aventis U.S. LLC | 1 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$578
- CAPLYTA$242
- Austedo XR$231
- LYBALVI$145
- INVEGA SUSTENNA$133
- INGREZZA$130
- Wegovy$125
- QELBREE$125
- REXULTI$125
How this compares
$4,311 in reported general payments places this provider in the 90th percentile of 180 gerontology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 100 | $1,626 |
| Quetiapine Fumarate | 67 | $960 |
| LantusInsulin Glargine,hum.Rec.Anlog | 13 | $956 |
| Hydroxyzine Hcl | 23 | $940 |
| Mirtazapine | 43 | $917 |
| Escitalopram Oxalate | 49 | $744 |
| Levothyroxine Sodium | 56 | $736 |
| Furosemide | 110 | $703 |
| Donepezil Hcl | 37 | $596 |
| Sertraline Hcl | 42 | $579 |
| Buspirone Hcl | 12 | $436 |
| Atorvastatin Calcium | 14 | $399 |
| Omeprazole | 16 | $385 |
| Pantoprazole Sodium | 14 | $374 |
| Warfarin Sodium | 32 | $342 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sanofi-aventis U.S. LLCLantus | $50 | $95613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 180 gerontology providers in Illinois.
Other gerontology in Rockford
- Stephanie VerderameRockford$15K
- Rhonda JohnsonRockford$5K
- Raquel RamirezRockford$448
- Molly EngelkesRockford$431
- Joseph StokesChicago$16K
- Megan BonisNiles$15K
- Cheryl RogersKankakee$15K
- June LosurdoHinsdale$9K
- Hayley MillsMoline$7K
- Carlyn NewellOlympia Fields$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.